HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Measles epidemiology and survey of measles immunity level among healthy population in Baoji City, Shaanxi Province, China.

Abstract
In this study, we analyzed the epidemiology of measles cases from January 2004 to December 2011 and measles immunity levels among a healthy population from January to June 2012, in Baoji, Shaanxi Province. This study aimed to identify susceptible populations to measles and to establish methods of measles prevention and control. Measles incidence was at the lowest level in 2011 (0.32 per 100,000 populations). Among these patients, the proportion of those younger than 8 months and those older than 27 years of age was relatively high. The overall antibody positive rate was 78.90%, and the average antibody geometric mean concentration was 562.15 mIU/ml. Measles immunity level was high among children aged 8 months to 6 years and low among infants aged 1-7 months. To reduce the incidence of measles among infants younger than 8 months, implementation of measles vaccine (MV) for women of childbearing age is recommended. Measles immunity level was low among some individuals vaccinated with aqueous MV and lyophilized MV. Supplementary immunization will be recommended for freshmen in universities and colleges, where many students are recruited from various parts of China.
AuthorsXiaoyu Zhang, Guangping Kou, Hongzhong Du, Zhoufeng Ju, Li Zhong, Xiuling Cui, Hongbing Ling
JournalJapanese journal of infectious diseases (Jpn J Infect Dis) Vol. 66 Issue 5 Pg. 449-53 ( 2013) ISSN: 1884-2836 [Electronic] Japan
PMID24047750 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Viral
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Antibodies, Viral (blood)
  • Child
  • Child, Preschool
  • China (epidemiology)
  • Cities
  • Female
  • Humans
  • Incidence
  • Infant
  • Infant, Newborn
  • Male
  • Measles (epidemiology, immunology)
  • Middle Aged
  • Urban Population
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: